LabCompass

Julia L. Agne

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2015Rising activity
Palliative Care and End-of-Life IssuesCancer survivorship and careChildhood Cancer Survivors' Quality of LifePain Management and Opioid UseOpioid Use Disorder Treatment

Publications

31

Citations

161

Est. group size

~8

Recurring co-author estimate

Active years

12

Publishing since 2015

Research summary
AI-generated

Julia L. Agne's research focuses on palliative and supportive care for people with cancer, including pain and symptom management, quality of life, and the integration of palliative care into oncology clinics. Her work spans topics like remote symptom monitoring, medication side effects, patient-provider relationships, and survivorship care, drawing on both clinical studies and patient-perspective research.

Palliative and end-of-life careCancer pain and symptom managementCancer survivorshipPatient-physician relationships and communicationIntegration of palliative care into oncology practice

Publication output has been fairly steady at a low level over most of the past decade with a notable spike in 2025, suggesting recent growth in activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.8/year recently
172018: 3 publications182019: 2 publications192020: 2 publications202021: 4 publications212022: 3 publications222023: 2 publications232024: 1 publication242025: 11 publications11252026: 2 publications26
Recent publications
Publishes in
  • Journal of Pain and Symptom Management×7
  • JCO Oncology Practice×4
  • Journal of the National Comprehensive Cancer Network×3
  • Supportive Care in Cancer×3
  • Journal of Thoracic Oncology×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile